OIG has new role for compliance committees: Risk assessment oversight

The U.S. Department of Health and Human Services Office of Inspector General (OIG) has added a new responsibility—risk assessment oversight—to health care organizations’ compliance committees through its corporate integrity agreements (CIAs).

Several CIAs issued in 2022 include a modified Risk Assessment and Internal Review Process section that states, “The Compliance Committee shall be responsible for implementation and oversight of the risk assessment and internal review process.”[1]

The risk assessment and internal review process, which should be conducted annually, requires organizations to:

This document is only available to members. Please log in or become a member.
 


Would you like to read this entire article?

If you already subscribe to this publication, just log in. If not, let us send you an email with a link that will allow you to read the entire article for free. Just complete the following form.

* required field